TMBIM6 overexpression enhanced proliferation, invasion, migration, GSH/GPX4 levels, and ferroptosis resistance while suppressing MDA, Fe2+, and lipid ROS in bladder cancer cells, effects reversed by Erastin. Here, GPX4 is linked to urinary bladder carcinoma.